Positions

Assistant Professor of Medicine in the School of Medicine

2021 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2013 School of Medicine

Education

M.D. 2004

2004 University of North Carolina, Chapel Hill

Resident, INTERNAL MEDICINE

2008 University of North Carolina, Chapel Hill, School of Medicine

Fellow, CLINICAL ONCOLOGY

2012 Johns Hopkins University, School of Medicine

Clinical Trials

The STOP-HER2 TBCRC062 Trial:Outcomes in Patients with HER2+ Metastatic Breast Cancer

Publications, Grants & Awards

• Grants (11)
• Academics Articles (2)

Showing 1-5 of 11

TBCRC45: AVIATOR: A Phase II Study Of Trastuzumab, Vinorelbine, and Avelumab ± PF-05082566 (4-1BB/CD137 Agonist) in HER2+ MBC

2019-2025Johns Hopkins University

AFT-05/PALLAS

2016-2025Alliance Foundation Trials, LLC

A Randomized, Open Label, Phase III Trial to Evaluate the Efficacy and Safety of Palbociclib + Anti-HER2 Therapy + Endocrine Therapy vs. Anti-HER2 Therapy + Endocrine Therapy after Induction Treatment for Hormone Receptor Positive (HR+)/HER2-Positive

2017-2025Alliance Foundation Trials, LLC

Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer

2019-2024Seattle Genetics, Inc

Addressing Sexual Concerns in Breast Cancer Survivors: RCT of a Novel Couple-Based Intervention

2018-2024Fox Chase Cancer Center

DCI Centers, Cancer Types & Labs

Breast Cancer

Offices & Contact

3459
Durham, NC
27710

3459
Durham, NC
27710